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Introduction: In an age of increasing scrutiny of each hospital admission, emergency department
(ED) observation has been identified as a low-cost alternative. Prior studies have shown admission
rates for syncope in the United States to be as high as 70%. However, the safety and utility
of substituting ED observation unit (EDOU) syncope management has not been well studied.
The objective of this study was to evaluate the safety of EDOU for the management of patients
presenting to the ED with syncope and its efficacy in reducing hospital admissions.
Methods: This was a prospective before-and-after cohort study of consecutive patients presenting
with syncope who were seen in an urban ED and were either admitted to the hospital, discharged,
or placed in the EDOU. We first performed an observation study of syncope management and then
implemented an ED observation-based management pathway. We identified critical interventions
and 30-day outcomes. We compared proportions of admissions and adverse events rates with a chisquared or Fisher’s exact test.
Results: In the “before” phase, 570 patients were enrolled, with 334 (59%) admitted and 27 (5%)
placed in the EDOU; 3% of patients discharged from the ED had critical interventions within 30 days
and 10% returned. After the management pathway was introduced, 489 patients were enrolled; 34%
(p<0.001) of pathway patients were admitted while 20% were placed in the EDOU; 3% (p=0.99) of
discharged patients had critical interventions at 30 days and 3% returned (p=0.001).
Conclusion: A focused syncope management pathway effectively reduces hospital admissions and
adverse events following discharge and returns to the ED. [West J Emerg Med. 2019;20(2)250–255.]

INTRODUCTION
Prior studies have shown admission rates for syncope
in the United States (U.S.) to be as high as 70%, triggering
at least 2% of hospital admissions from the emergency
department (ED) and 460,000 hospitalizations annually.1-3
Although emergency medicine has become more adept at
Western Journal of Emergency Medicine

distinguishing high-risk syncope from syncope of benign
etiology and safety in ED discharge, there is a paucity of data
addressing the care of patients once the ED recognizes a need
for admission or further management.4-17 Recent data note that
a typical hospital admission in the U.S. for syncope averages
$5,300 with a total cost of syncope-related admissions of over
250
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$2 billion per year.1-3, 16-21 These costs have been directly related to
the broad diagnostic testing performed to discover the etiologies
of syncope.20 Not unexpectedly then, syncope was recently noted
to be the leading diagnosis associated with payment denials by
the Centers for Medicare and Medicaid Services.22
As short hospital-inpatient stays and hospital readmissions
undergo increased scrutiny, ED observation units (EDOU) are
increasingly being used as a low-cost alternative to inpatient
hospitalization. While efforts to reduce unnecessary and
expensive admission have generated clinical decision guidelines
regarding the decision to admit, they have only begun to assess
the value and yield of testing in syncope and have not fully
assessed the utility of expedited care in an observation unit.23-24
The safety of substituting ED observation for in-house care in
syncope has not been well studied. The objective of this study
was to evaluate the utility and safety of an ED observation-based
management pathway for the evaluation of patients presenting to
the ED following a syncopal event.
METHODS
Study Design and Setting
This was a prospective cohort before-and-after study
conducted in a large, urban teaching hospital with an annual
ED census of 56,000 and an annual ED observation volume of
approximately 6,000 visits. We performed an observational study
of consecutive patients with syncope who were initially seen in
the ED and were either admitted to the hospital, discharged or
placed in an EDOU. We then implemented an ED-based, focused
management pathway – the Boston Syncope Management
Pathway (BSCMP) – to investigate the outcomes of these patients
who presented to the ED with syncope (Figure). The BSCMP
was derived by emergency physicians (EP) and cardiologists to
create individualized workups for syncope based on presenting
symptoms and comorbidities. The derivation used preexisting
medical literature evaluating care of patients with syncope.2, 9,
11-16
Institutional review board approval was obtained prior to
initiation of the study.
Selection of Participants
Inclusion criteria were as follows: 1) age 18 years or older;
and 2) ED patients presenting with syncope or near syncope
and admitted by the ED team to either an inpatient ward or
EDOU. We defined syncope as a sudden and transient (< five
minutes) loss of consciousness producing a brief period of
unresponsiveness and a loss of postural tone ultimately resulting
in spontaneous recovery requiring no resuscitation measures.9,
17
Near syncope was defined as “feeling like they were going to
pass out” but without actual loss of consciousness. Exclusion
criteria were patients discharged home directly from the ED
without an observation stay, patients with persistent altered
mental status, alcohol or illicit drug-related loss of consciousness,
seizure, coma, hypoglycemia, or transient loss of consciousness
caused by head trauma.
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Population Health Research Capsule
What do we already know about this issue?
Although emergency department (ED)
observation has been utilized for syncope,
the safety and maximal utility of substituting
ED observation for in-house care in syncope
has not been well studied.
What was the research question?
This study aimed to evaluate the safety
and effectiveness of an ED management
Observation Pathway.
What was the major finding of the study?
A syncope management observation
pathway reduced hospital admissions and
adverse events, when compared to standard
ED or inpatient care.
How does this improve population health?
With rising health care costs, hospital
crowding, and increased ED boarding, a
syncope management pathway is reliable,
safe, and effective for ED patients.

Outcome Measures
The primary outcome was the utility of the BSCMP for
the management of patients presenting to the ED with syncope.
Secondary outcomes looked at the efficacy of the pathway in
reducing hospital admissions and improving patient disposition.
We defined significant events, as has been defined previously, to
include critical interventions such as pacemaker or defibrillator
placement, percutaneous coronary intervention, surgery, blood
transfusion, cardiopulmonary resuscitation, endoscopy and
carotid artery interventions, or adverse outcomes such as death,
pulmonary embolus, myocardial infarction, cerebrovascular
accident, dysrhythmia, cardiac arrest, intracranial hemorrhage
or sepsis.6 We made secondary comparisons for patient
demographics, comorbidities, and other features of their clinical
presentation based on inpatient vs EDOU admission.
Data Collection and Processing
An electronic ED dashboard that interfaced with a
commercially available healthcare information system
automatically tracked all ED patients, identifying and flagging
those with complaints of syncope, near syncope or loss
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All patients should have orthostatic blood pressure measured*
All positive or equivocal tests should generate a cardiology consult or admission

I. Signs and symptoms of acute coronary syndrome
a. Includes: Chest pain or shortness of breath of possible cardiac origin electrocardiogram or new (or not known to be old STT
wave change, Ischemic ECG changes (ST elevation or deep [>0.1 mV] ST depression)
b. Workup: Serian trigeminal neuralgia and stress testing (consider stress echo). If obvious ischemia then admit.
II. Worrisome cardiac history
a. Includes: History of coronary artery disease, including deep q waves, hypotrophic or dialated cardiomyopathy. History
of congestive heart failure or left ventrical dysfuntion, history of ventricular tachycardia/ventricular fibrillation, permanent
pacemaker, implantable cardioverter-defibrillator, pre-hospital use of anti-dysrhythmic medication
b. Workup: Echo (in none in the last six months) and telemetry
III. Family history of sudden death
a. Includes: Family history (first degree relative) with sudden death, hypertrophic cardiomyopathy, Brugada’s syndrome or
long QT syndrome
b. Workup: Echo, telemetry and ambulatory home monitoring
IV. Valvular heart disease
a. Includes: Heart murmur noted in history or on emergency department (ED) examination not fully evaluated in the past six months
b. Workup: Telemetry, echo, ambulatory monitoring
V. Signs of conduction disease
a. Includes: Tachy or bradysrhythmias in ED, QT interval >500, Brugada, Wolff-Parkinson-White, multiple syncopal episodes
within the last six months, palpations, syncope during exercise
b. Workup:Telemetry, ambulatory monitoring, consider echo and stress testing
VI. Volume depletion
a. Includes: Gastrointestinal bleeding by hemoccult or history, hematocrit <30, dehydration not corrected in the ED per treating
physician discretion
b. Workup: Follow gastrointestinal bleed pathway or hydrate and repeat complete blood count, electrolytes in the morning
VII. Persistent (>15 minutes) abnormal vital signs in the ED without need of concurrent interventions such as oxygen, pressors,
temporary pacemakers
a. Includes: Respiratory rate >24 beats/minute, blood pressure <90 mmHg, O2 saturation <90%, sinus rate <50 beats/minute
or sinus rate >100 beats/minute
b. Workup: Telemetry and echo
VIII. CNS (excluding clear subarachnoid hemorrhage, transient ischemic attack, stroke) or similar concerns
a. Includes: Headache, neuro symptoms, neuro deficit or anticoagulated
b. Workup: Head computed tomography if positive-neuro or neurosurgery consult
*Orthostatic blood pressure
•
Blood pressure and heart rate after patient quietly supine for five minutes and after one minute and three minutes of standing
Figure. Boston Syncope Pathway to guide the management of patients with syncope in the emergency department. This is a validated
pathway for the management of syncope in the ED.6

of consciousness for provider enrollment. In addition, the
investigators routinely reviewed daily patient logs to ensure
appropriate pathway enrollment and identify missed patients. The
ED dashboard does not allow for a physician to place a patient
disposition without enrolling (with a written explanation) or
declining pathway placement. A chart review was then performed
of these patients reviewing their ED and EDOU or hospital
course. Finally, we recorded outcomes at 30 days following initial
presentation to the ED mainly via medical record reviews and a
few through phone calls.
Primary Data Analysis
We entered data into a RedCap database. Categorical data
was then analyzed using either chi-squared or Fisher’s exact test.
We analyzed continuous data using Student’s t-test. Results are
reported as percentages.

Western Journal of Emergency Medicine

RESULTS
Patient demographics and comorbidities pre- and postpathway are described in Table 1. These show a slightly older
population in the post-pathway group with significantly fewer
signs of acute coronary syndrome or signs of conduction disease;
however, they indicated more worrisome cardiac history, valvular
heart disease, and abnormal vital signs. As described in Table
2, prior to implementation of the BSCMP, of the 570 patients
enrolled, 344 (58.6%) were fully admitted and 27 (4.7%) were
placed in the EDOU. A total of 209 (36.7%) patients were
discharged immediately following ED evaluation. After the
pathway was introduced, 489 patients were enrolled. Of the 489
patients enrolled, 164 (33.5%) were admitted and 96 (19.6%)
were placed in the EDOU. More patients were discharged directly
from the ED to home in the post-pathway vs pre-pathway studies
(36.7% vs 46.8%; p<0.001). The observation unit post-BSCMP
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Table 1. Patient demographics and risk factors for adverse outcomes in syncope; pre and post-pathway.
Pre-pathway
Number of patients

Post-pathway

P value

570

489

-

53.6 (24.2)

56.7 (22.8)

0.03

26.1% (149)

13.5% (66)

<0.001

Signs of conduction disease (recurrent syncope, palpitations, syncope with
exercise, QT > 500 ms, heart block)

13.5% (77)

8.4% (41)

<0.01

Worrisome cardiac history (CAD, CHF, V-tach, pacemaker, ICD)

33% (188)

41% (201)

<0.01

4% (23)

7% (35)

0.03

Age, mean (SD)
Male, % (n)
Risk factors
Signs of ACS (chest pain, ischemic, SOB, abnormal heart rhythm)

Valvular heart disease (i.e. significant murmur)
Family history of sudden death
Persistent abnormal vital signs in ED (RR>24, O2<90, HR<50 or >100, SBP<90)

2% (11)

0.8% (4)

0.19

6.5% (37)

17% (83)

<0.001

6% (34)

8% (38)

0.24

Volume depletion (GIB, Hct < 30, profound dehydration)

Primary CNS event
1% (7)
2% (12)
0.17
SD, standard deviation; ACS, acute coronary syndrome; SOB, shortness of breath; CAD, coronary artery disease; CHF, congestive
heart failure; V-tach, ventricular tachycardia; ICD, implantable cardioverter-defibrillator; ED, emergency department; SBP, systolic blood
pressure; HR, heart rate; GIB, gastrointestinal bleed; Hct, hematocrit; CNS, central nervous system.

Table 2. Comparison of pre-pathway and post-pathway
admission, emergency department observational (ED Obs), and
discharged patients.
Pre-pathway
Number of patients
Admitted
ED Obs
Discharged

Post-pathway

Table 3. Return visits to the emergency department (ED) and 30day adverse events (AE).
Pre-pathway

P value

570

489

-

58.6%(334)

33.5% (164)

p<0.001

4.7% (27)

19.6% (96)

p<0.001

36.7% (209)

46.8 (229)

p<0.001

Discharged
Return ED Visit
30-Day AE

managed 96 (19.6%) patients presenting to the ED for syncope
vs 27 (4.7%) prior to pathway implementation (p<0.001). Of the
patients placed in the EDOU, 11 (11.4%) were admitted from the
EDOU.
As described in Table 3, of the 209 discharged patients
from the ED, prior to the management pathway 21 (10%)
returned to the ED for syncope. In comparison to the postpathway cohort, only six (2.6%) re-presented to the ED for
syncope after discharge (p=0.001). Although return visits
decreased among discharged patients post pathway, 30-day
adverse events were similar for these groups. Pre-pathway,
30-day adverse events were 3% (6/209) vs 3% (7/229; p=0.99)
post-pathway. Table 4 describes the pre- and post-pathway 30day return diagnoses post-discharge for syncope.
DISCUSSION
Our data suggest that a focused syncope management
pathway may effectively reduce hospital admissions without

Volume 20, no. 2: March 2019

Post-pathway

P value

209

229

-

10% (21)

2.6% (6)

0.001

3% (6)

3% (7)

p<0.99

increasing adverse events following discharge. EDOUs were
designed to provide focused care in lieu of admission, with
an expectation of discharge within 24 hours. The utility
of ED observation has long been established for patients
with diagnoses such as chest pain, asthma, congestive heart
failure, and cellulitis, which in the past would often result
in short hospital stays.25-29 Like chest pain, syncope is a
common presentation that uncommonly signifies a dangerous,
underlying condition and should be amenable to this approach.
The BSCMP was designed to direct care and refocus EPs
not only in differentiating life threats from less-dangerous
causes of syncope but to enable the EP to selectively manage
those patients with potential risk factors for adverse event.
To do so, the pathway directs physicians toward testing in
fixed circumstances and to discharge patients who are low
risk based on the BSCMP.6 Lastly, if neither the EDOU nor
discharge is appropriate, the pathway recommends admission.
This, in turn, likely reflects the broad spectrum of diseases that
syncopal etiologies span, from potentially life-threatening to
low-risk diagnoses.
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Table 4. Description of return adverse events after discharge.
Pre-pathway (n=6/209)
discharged

Address for Correspondence: Oren Mechanic, MD, MPH, Beth
Israel Deaconess Medical Center, Department of Emergency
Medicine, 1 Deaconess Rd, Rosenberg 2nd Fl, Boston, MA
02215. Email: omechani@bidmc.harvard.edu.

Post-pathway (n = 7/229)
discharged

Myocardial infarction= 1

Anemia requiring transfusion= 1

PCI/surgery= 1

Vaginal bleed= 1

Ventricular dysrhythmia= 1

Ventricular tachycardia= 1

GI bleed=1

Death= 1

PE= 1

Surgery= 3
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funding sources and financial or management relationships that
could be perceived as potential sources of bias. No author has
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Sepsis= 1
PCI, percutaneous coronary intervention; GI, gastrointestinal; PE,
pulmonary embolism.
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A prior study comparing an ED observation syncope
protocol and routine inpatient admission found that
observation reduced admission rates and hospital length of
stay with no differences in 30-day quality-of-life scores or
patient satisfaction.30,31 This study also suggested a reduction
in hospital costs, with no difference in safety.30 We believe the
BSCMP takes this one step further, as our data suggest not
only a reduction in admission rates but a significant decrease
in the number of returns and readmissions to the hospital for
syncope patients. Given the financial constraints involved
in the current healthcare climate, this finding becomes
increasingly significant.
While fewer than one-third of EDs currently have
EDOUs, this number is growing and our ability to
adequately care for these growing patient populations needs
to be commensurate.
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